Democrats get backlash for calling testosterone screening gender care

Key Points:

• Democratic senators, including Adam Schiff and Mazie Hirono, faced criticism online for equating the Pentagon’s new testosterone testing and treatment program with gender-affirming care for transgender individuals.
• The Pentagon, led by Secretary of War Pete Hegseth, announced testosterone screening for service members over 30 to address testosterone deficiency, emphasizing the goal of restoring natural hormone levels to maintain physical readiness.
• Critics argue that testosterone replacement therapy for men with deficiency is a medical treatment distinct from gender-affirming care, which involves different interventions for transgender individuals.
• Supporters of the program highlight the importance of testosterone in maintaining muscle mass, bone density, energy, and overall health, viewing the initiative as a necessary step to improve service members' well-being and combat readiness.
• The debate reflects broader political tensions, with some Democrats framing the program as contradictory to their support for trans rights, while others and medical experts defend it as a legitimate health measure unrelated to gender identity.